Corcept Therapeutics | CORT - Umlaufvermögen

Aktienkurs
46.62
Täglich Wechseln
0.40 0.87%
Monatlich
22.30%
Jährlich
-36.34%
Q2 Prognose
45.07




Umlaufvermögen Veränderung Datum
Acadia Pharmaceuticals USD 1.06B 14.31M 2025-12
Alaunos Therapeutics USD 2.68M 1.05M 2025-09
ANI Pharmaceuticals USD 753.12M 54.72M 2025-12
Ardelyx USD 382.32M 14.33M 2025-12
Assertio Holdings USD 263.57M 53.36M 2025-09
Aurora Cannabis CAD 445.84M 22M 2025-12
BioMarin Pharmaceutical USD 3.95B 98.95M 2025-12
Bristol-Myers Squibb USD 35.63B 2.41B 2025-09
Canopy Growth CAD 524.67M 78.85M 2025-12
Corcept Therapeutics USD 485.46M 55.67M 2025-12
Eli Lilly USD 55.63B 6.44B 2025-12
Esperion Therapeutics USD 462.57M 102.11M 2025-12
J&J USD 59.17B 3.55B 2026-03
Knight Therapeutics CAD 394.84M 5.86M 2025-12
Lexicon Pharmaceuticals USD 101.9M 20.63M 2025-12
Merck USD 47.56B 10.49B 2025-09
Nektar Therapeutics USD 266.27M 15.09M 2025-12
Novartis USD 30.46B 2.26B 2025-12
Novartis USD 30.46B 2.26B 2025-12
Omeros USD 69.65M 26.53M 2025-06
Pacira USD 547.97M 14.78M 2025-12
Pfizer USD 46.92B 3.22B 2025-09
Supernus Pharmaceuticals USD 644.18M 50.29M 2025-12
TG Therapeutics USD 630.76M 31M 2025-12